Prospective Phase II Study Evaluating the Feasibility of a Conformational Pelvic and Prostatic Radiotherapy With Simultaneous Integrated Boost Modulated-intensity Arctherapy (SIB-IMAT) in Combination With Long Term Androgen Deprivation for High Risk Localized Prostate Cancer.
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Number of Participants with Acute urinary and rectal toxicities as a Measure of treatment specific Safety and Tolerability
Acute urinary and rectal toxicities will be assessed according to the NCI CTCAE v4.0 quotation each week during radiotherapy treatment period up to six months after the end of the radiotherapy treatment period.
From start of radiotherapy to six months after the end of radiotherapy
Etienne MARTIN, MD
Centre Georges-François Leclerc
France: Agence Nationale de Sécurité du Médicament et des produits de santé